Arbutus Biopharma

$3.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.18 (+5.01%) Today
+$0.07 (+1.86%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell ABUS and other stocks, options, and ETFs commission-free!

About ABUS

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA. The listed name for ABUS is Arbutus Biopharma Corporation Common Stock.

CEO
William H. Collier
Employees
80
Headquarters
Warminster, Pennsylvania
Founded
2005
Market Cap
320.11M
Price-Earnings Ratio
Dividend Yield
Average Volume
2.50M
High Today
$3.87
Low Today
$3.61
Open Price
$3.61
Volume
1.81M
52 Week High
$9.02
52 Week Low
$0.88

Collections

ABUS Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 4, Pre-Market

You May Also Like